- Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
-
Chung WJ
- KMID: 1392905
- Clin Mol Hepatol.
- 2012 Sep;18(3):268-271.
- doi: 10.3350/cmh.2012.18.3.268
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Adenosquamous carcinoma of the liver
-
Park SY, Cha EJ, Moon WS
- KMID: 1392914
- Clin Mol Hepatol.
- 2012 Sep;18(3):326-329.
- doi: 10.3350/cmh.2012.18.3.326
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic angiomyolipoma with minimal fat, mimicking hepatocellular carcinoma
-
Lee SJ, Kim SY, Kim KW, Shin YM, Kim HJ, Lee JS, Kim SA
- KMID: 1392915
- Clin Mol Hepatol.
- 2012 Sep;18(3):330-335.
- doi: 10.3350/cmh.2012.18.3.330
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period
-
Song DS, Bae SH
- KMID: 1392904
- Clin Mol Hepatol.
- 2012 Sep;18(3):258-267.
- doi: 10.3350/cmh.2012.18.3.258
Hepatocellular carcinoma (HCC) is the third most common cause of cancer deaths in the world. There have been many advances in the diagnosis of HCC during the last ten years,... -
- CITED
-
- Close
- SHARE
-
- Close
- Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma
-
Park SJ, Kim CH, Kim JD, Um SH, Yim SY, Seo MH, Lee DI, Kang JH, Keum B, Kim YS
- KMID: 1392912
- Clin Mol Hepatol.
- 2012 Sep;18(3):316-320.
- doi: 10.3350/cmh.2012.18.3.316
Transcatheter arterial chemoembolization (TACE) has been used widely to treat patients with unresectable hepatocellular carcinoma. However, this method can induce various adverse events caused by necrosis of the tumor itself... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug-induced liver injury: present and future
-
Suk KT, Kim DJ
- KMID: 1392903
- Clin Mol Hepatol.
- 2012 Sep;18(3):249-257.
- doi: 10.3350/cmh.2012.18.3.249
Liver injury due to prescription and nonprescription medications is a growing medical, scientific, and public health problem. Worldwide, the estimated annual incidence rate of drug-induced liver injury (DILI) is 13.9-24.0... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma
-
Bae SI, Yeon JE, Lee JM, Kim JH, Lee HJ, Lee SJ, Suh SJ, Yoon EL, Kim HR, Byun KS, Seo TS
- KMID: 1392913
- Clin Mol Hepatol.
- 2012 Sep;18(3):321-325.
- doi: 10.3350/cmh.2012.18.3.321
Necrotizing pancreatitis is one of the rare complications of transcatheter arterial chemoembolization (TACE). Necrotizing pancreatitis after TACE may result from the development of ischemia caused by regurgitation of embolic materials... -
- CITED
-
- Close
- SHARE
-
- Close
- Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
-
Kwon SH, Jeong SW, Jang JY, Lee JE, Lee SH, Kim SG, Kim YS, Cho YD, Kim HS, Kim BS, Jin SY
- KMID: 1392908
- Clin Mol Hepatol.
- 2012 Sep;18(3):287-294.
- doi: 10.3350/cmh.2012.18.3.287
BACKGROUND/AIMS: Cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) are up-regulated in hepatocellular carcinoma (HCC). To investigate the levels of COX-2 and VEGF expression in chronic hepatitis (CH), cirrhosis, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Thrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinoma
-
Lee HS, Park SY, Kim SK, Kweon YO, Tak WY, Cho CM, Jeon SW, Jung MK, Park HG, Lee DW, Choi SY
- KMID: 1392910
- Clin Mol Hepatol.
- 2012 Sep;18(3):302-308.
- doi: 10.3350/cmh.2012.18.3.302
BACKGROUND/AIMS: We evaluated changes in liver function parameters and risk factors for the deterioration of liver function 12 months after percutaneous radiofrequency ablation (RFA) therapy in patients with hepatocellular carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH
-
Yoon MY, Sung JM, Song CS, Lee WY, Rhee EJ, Shin JH, Yoo CH, Chae SW, Kim JY, Jin W, Cho YK
- KMID: 1392907
- Clin Mol Hepatol.
- 2012 Sep;18(3):279-286.
- doi: 10.3350/cmh.2012.18.3.279
BACKGROUND/AIMS: Adipose tissue is an active endocrine organ that secretes various metabolically important substances including adipokines, which represent a link between insulin resistance and nonalcoholic steatohepatitis (NASH). The factors responsible... -
- CITED
-
- Close
- SHARE
-
- Close
- Type and cause of liver disease in Korea: single-center experience, 2005-2010
-
Lee SS, Byoun YS, Jeong SH, Kim YM, Gil H, Min BY, Seong MH, Jang ES, Kim JW
- KMID: 1392911
- Clin Mol Hepatol.
- 2012 Sep;18(3):309-315.
- doi: 10.3350/cmh.2012.18.3.309
BACKGROUND/AIMS: The aim of this study was to describe the types and causes of liver disease in patients from a single community hospital in Korea between April 2005 and May... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus
-
Ahn SJ, Kim DK, Kim SS, Bae CB, Cho HJ, Kim HG, Kim YJ, Lee JH, Lee HJ, Lee MY, Kim KB, Cho JH, Cho SW, Cheong JY
- KMID: 1392909
- Clin Mol Hepatol.
- 2012 Sep;18(3):295-301.
- doi: 10.3350/cmh.2012.18.3.295
BACKGROUND/AIMS: Apolipoprotein E (ApoE) plays an important role in regulating lipid and lipoprotein metabolism, and ApoE genotypes are known to affect plasma lipoprotein concentrations. We investigated whether ApoE genotype determines... -
- CITED
-
- Close
- SHARE
-
- Close
- A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
-
You BC, Kim YS, Kim HI, Kim SH, Park SS, Seo YR, Kim SG, Lee SW, Kim HS, Jeong SW, Jang JY, Kim BS
- KMID: 1392906
- Clin Mol Hepatol.
- 2012 Sep;18(3):272-278.
- doi: 10.3350/cmh.2012.18.3.272
BACKGROUND/AIMS: When combined with pegylated interferon alpha-2b (Peg-IFN alpha-2b) for the treatment of genotype 1 chronic hepatitis C (CHC) in Korea, the current guideline for the initial ribavirin (RBV) dose... -
- CITED
-
- Close
- SHARE
-
- Close
